Choice of therapeutic anti-seizure medication in patients with brain tumour

J Pak Med Assoc. 2019 Mar;69(3):442-444.

Abstract

Seizures are common in patients with brain tumours, even though prophylactic anti-seizure treatment for all patients with brain tumours is not recommended. Newer anti-epileptic drugs have shown benefits that outweigh the side effects of treatment and can also be given in combination with traditional anti-epileptic drugs. The authors have reviewed the literature on the various combinations of anti-epileptics in patients with seizures and brain tumours.

Keywords: Seizures, anti-epileptic drugs, brain tumours..

Publication types

  • Review

MeSH terms

  • Anticonvulsants / therapeutic use*
  • Brain Neoplasms / complications
  • Brain Neoplasms / therapy*
  • Drug Therapy, Combination
  • Epilepsy / drug therapy*
  • Epilepsy / etiology
  • Gabapentin / therapeutic use
  • Glioma / complications
  • Glioma / therapy*
  • Humans
  • Lamotrigine / therapeutic use
  • Levetiracetam / therapeutic use
  • Neoplasm Grading
  • Phenytoin / therapeutic use
  • Survival Rate
  • Topiramate / therapeutic use
  • Valproic Acid / therapeutic use
  • Zonisamide / therapeutic use

Substances

  • Anticonvulsants
  • Topiramate
  • Levetiracetam
  • Zonisamide
  • Valproic Acid
  • Phenytoin
  • Gabapentin
  • Lamotrigine